Abraham N. Ceesay


Abraham N. Ceesay has served as our President since May 2021.

Mr. Ceesay has nearly two decades of experience in leading biopharmaceutical companies and commercializing innovative therapeutic products. Mr. Ceesay previously served as the chief executive officer at Tiburio Therapeutics, where he built a fully integrated company that led to the investigational new drug application enablement for a rare neuroendocrine tumor.

Prior to joining Tiburio, Mr. Ceesay served as chief operating officer at scPharmaceuticals, where he developed and led all operational and commercial aspects of the company. Prior to joining scPharmaceuticals, he served as the head of commercial (sales, marketing, and commercial operations) at Keryx Biopharmaceuticals, vice president of marketing at Ironwood Pharmaceuticals, and in roles of increasing responsibility at Sanofi, formerly Genzyme.

Mr. Ceesay serves on the Board of Directors for Life Science Cares and Camp Harbor View. He holds a bachelor’s degree from Ithaca College, and a Master of Business Administration from Suffolk University’s Sawyer School of Management.

Roles at Cerevel Therapeutics

  • President

    May 3, 2021 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Cerevel Therapeutics

My pet peeves

My communication style